The U.S. Food and Drug Administration’s vaccine advisory committee has recommended the emergency use of Moderna’s COVID-19 vaccine candidate mRNA-1273. If authorized, it would be the second COVID-19 vaccine available
Continue reading »Home »
CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data
Today’s Daily Dose brings you news about BioCryst’s update on its investigational broad-spectrum antiviral Galidesivir in the treatment of COVID-19, a $7 million strategic investment by Acorn Bioventures in Cyclacel
Continue reading »The FDA has approved the first genetically modified pig for people with meat allergies
The FDA has approved a genetically modified pig for both human consumption and medicinal purposes. The pigs lack alpha-gal sugar, which causes an allergic reaction in those who have alpha-gal
Continue reading »BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech’s COVID-19 Vaccine Gets Green Light In UK
Today’s Daily Dose brings you news about the UK authorizing Pfizer/BioNTech’s COVID-19 mRNA vaccine BNT162b2 for emergency use, the anticipated event of BioCryst Pharma, Janssen acquiring rights to investigational gene
Continue reading »Week Ahead In Pharma: EIGR Scripts History With Progeria Treatment, LQDA, RYTM Await FDA Decision
The week ending November 20 saw some more good news on the COVID-19 front, with Pfizer (PFE) and German biotechnology company BioNTech (BNTX) making emergency use approval request to the
Continue reading »WuXi Biologics CEO expects approval for Covid-19 antibody treatment 'late this year or early next year'
Companies around the world are racing to make vaccines and other therapeutics to combat the virus that causes Covid-19. "We are working on 10 neutralizing antibodies and also on one
Continue reading »Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN…
What’s moving these stocks in the pre-market hours today? In the Green 1. Altimmune Inc. (ALT) is up over 15% at $9.04 in pre-market hours, gaining half of what it
Continue reading »Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN…
What’s moving these stocks in the pre-market hours today? In the Green 1. Altimmune Inc. (ALT) is up over 15% at $9.04 in pre-market hours, gaining half of what it
Continue reading »Pre-market Movers In Healthcare Sector: FPRX, ZSAN, IVA, TDOC, INO…
What’s moving these stocks in the pre-market hours today? In the Green 1. Five Prime Therapeutics, Inc. (FPRX) is up over 310% at $21.95 in pre-market trading Wednesday, on the
Continue reading »FDA panel reviews 1st new Alzheimer’s drug in 2 decades
Fox Business Go Watch Fox Business Network streaming live on the web. One of the biggest drug decisions in decades is looming as U.S. regulators consider whether to approve the
Continue reading »